These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38226560)

  • 1. Efficacy of oral 5 mg melatonin in the treatment of facial melasma in women: A double-blind, randomized, placebo-controlled clinical trial.
    Holanda IRM; de Almeida Corrêa Alfredo M; Cassiano DP; Esposito ACC; Lima PB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):e607-e609. PubMed ID: 38226560
    [No Abstract]   [Full Text] [Related]  

  • 2. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.
    Lyons A; Stoll J; Moy R
    J Drugs Dermatol; 2018 Sep; 17(9):970-973. PubMed ID: 30235384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral melatonin in recalcitrant melasma.
    Sarkar R; Verma B; Mendiratta V
    Int J Dermatol; 2024 Aug; 63(8):1111-1112. PubMed ID: 38650083
    [No Abstract]   [Full Text] [Related]  

  • 5. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2009 Aug; 8(8):732-5. PubMed ID: 19663110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma.
    Ahmed AM; Lopez I; Perese F; Vasquez R; Hynan LS; Chong B; Pandya AG
    JAMA Dermatol; 2013 Aug; 149(8):981-3. PubMed ID: 23740292
    [No Abstract]   [Full Text] [Related]  

  • 7. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
    Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Blind, Placebo Controlled Evaluation of a Novel Skin Lightening Agent.
    Spencer JM; Accioly J; Kitchen N
    J Drugs Dermatol; 2018 Jan; 17(1):113-115. PubMed ID: 29320596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
    Mansouri P; Farshi S; Hashemi Z; Kasraee B
    Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial.
    Dias JAF; Lima PB; Cassiano DP; Espósito ACC; Bagatin E; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e123-e125. PubMed ID: 34553413
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatments for melasma: adjuvant therapy with a novel topical agent.
    Cohen PR
    Int J Dermatol; 2018 Mar; 57(3):e20-e21. PubMed ID: 29313951
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
    Farshi S; Mansouri P; Kasraee B
    J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.
    Haddad AL; Matos LF; Brunstein F; Ferreira LM; Silva A; Costa D
    Int J Dermatol; 2003 Feb; 42(2):153-6. PubMed ID: 12709008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial.
    Galache TR; Galache M; Sena MM; Pavani C
    BMJ Open; 2023 Jul; 13(7):e073568. PubMed ID: 37479524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.